Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.89 NOK | -4.49% | -10.71% | -53.62% |
05-29 | BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-29 | Transcript : BerGenBio ASA, Q1 2024 Earnings Call, May 29, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
50.41M | - | - | ||||
121B | ||||||
107B | ||||||
24.82B | - | |||||
22.48B | - | |||||
18.32B |
- Stock Market
- Equities
- BGBIO Stock
- Charts BerGenBio ASA
- Sector Chart